New York Times Chinese Website's commentary today (August 18) has sparked heated discussions. The New York Times wrote: "America's 'life-saving medicine' may come from China. The advantages of China's biotechnology industry lie in its efficiency and low cost. Embracing China's progress and increasing access to medicines produced in China can provide Americans with more affordable drugs and treatment options. Both China and the United States are competing to make people live longer and healthier lives. If China has found a faster and cheaper way to achieve this goal, Americans should not fall behind due to political factors."
[Witty] Comments: In the early 20th century, the United States propelled the rise of the biotechnology industry through technological innovation and mass production, providing citizens with more affordable medicines and treatment options. Today, China's biotechnology industry is developing with the advantages of efficiency and low cost, which is quite similar to the development path the United States took back then. Separated by a century, both highlight the importance of national scientific and technological advancement and the health of the people. The competition between China and the United States in the field of biotechnology is essentially a contest of innovation and efficiency, and the United States should not ignore this trend due to political factors. As the New York Times said, Americans should not lag behind China's progress due to political factors. Instead, if the United States can set aside prejudice and cooperate with China, it will be able to jointly promote the development of this field and make greater contributions to human health and well-being.
Original: www.toutiao.com/article/1840806529163335/
Statement: This article represents the views of the author himself.